CytoDyn Inc. Incremental Common Shares Attributable to Dilutive Effect of Conversion of Preferred Stock
CytoDyn Inc. (CYDY) reported Incremental Common Shares Attributable to Dilutive Effect of Conversion of Preferred Stock of 0 shares for the 12-month period ending 2026-05-31, per its 10-K filed 2026-08-31.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:IncrementalCommonSharesAttributableToConversionOfPreferredStock · last filed 2026-08-31
- CytoDyn Inc. incremental common shares attributable to dilutive effect of conversion of preferred stock for the quarter ending 2024-08-31 was 37.79M shares.
- CytoDyn Inc. incremental common shares attributable to dilutive effect of conversion of preferred stock for fiscal 2026 was 0.00 shares, a 100.00% decline from fiscal 2025.
- CytoDyn Inc. incremental common shares attributable to dilutive effect of conversion of preferred stock for fiscal 2025 was 2.35M shares.
| Period end | Incremental Common Shares Attributable to Dilutive Effect of Conversion of Preferred Stock 3 month | Incremental Common Shares Attributable to Dilutive Effect of Conversion of Preferred Stock 9 month | Incremental Common Shares Attributable to Dilutive Effect of Conversion of Preferred Stock 12 month |
|---|---|---|---|
| 2026-05-31 | 0.00 shares 10-K · filed 2026-08-31 | ||
| 2025-05-31 | 2.35M shares 10-K · filed 2026-08-31 | ||
| 2025-02-28 | 625.00K shares S-1 · filed 2026-04-22 | ||
| 2024-08-31 | 37.79M shares 10-Q · filed 2025-10-10 |